医院药学人员新型冠状病毒感染的暴露防护对策

Exposure Protection Countermeasures for Novel Coronavirus Infection in Hospital Pharmaceutical Staff

目的:为医院药学人员新型冠状病毒(SARS-CoV-2)感染的暴露防护提供参考。方法:根据医务人员防护相关指南的推荐,结合新型冠状病毒肺炎(COVID-19)疫情特点和防控管理的要求,基于暴露防护的基本原则,对医院药学人员工作岗位实际存在的感染暴露风险进行评估,并构建COVID-19疫情下医院药学人员暴露防护对策。结果:经遵循标准预防原则和感染暴露风险评估,医院药学工作岗位大部分属于低风险暴露岗位,仅个别岗位属于中、高风险暴露岗位。应根据不同药学岗位暴露风险级别,视工作需要配备个人防护用品。同时应强化人员的感染防护培训,做好工作环境和设施的清洁消毒。结论:COVID-19疫情期间,医院药学人员应践行标准预防原则,基于医院药学的工作岗位特点和暴露风险,按照药学部门确定的暴露风险级别和相关的管理规定进行个人防护,避免过度防护或防护不足,从而保障顺利、安全地开展药学服务。

OBJECTIVE:To provide reference for exposure protection countermeasures for Novel coronavirus(SARS-CoV-2)infection in hospital pharmaceutical staff. METHODS:According to the recommendations of related medical staff protection guideline,combined with the characteristics and prevention and control requirements of novel coronavirus pneumonia(COVID-19),based on the basic principle of exposure protection,actual exposure risk of infections for hospital pharmaceutical staff were evaluated, and the countermeasures for exposure protection were constructed under the epidemic condition of COVID-19.RESULTS:According to the standard prevention principle and the risk evaluation of infection exposure,most of the pharmaceutical posts in the hospital belonged to low-risk exposure posts,and only a few posts belonged to medium-and high-risk exposure posts.Personal protective equipment should be provided according to the exposure risk level of different pharmaceutical posts and work demand. At the same time,infection protection training should be strengthened;environment and facilities in pharmacy should be cleaned and disinfected. CONCLUSIONS:Standard prevention principle should be followed by hospital pharmaceutical staff during epidemic period. Based on the characteristics and exposure risks of pharmacy posts,and according to the regulations of the hospital,personal protection for hospital pharmaceutical staff should be conducted according to the exposure risk level determined by the pharmaceutical department and relevant management regulations to avoid over-protection or inadequate protection,so as to ensure the smooth and safe development of pharmaceutical care.